Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

Kazutaka Hosoya, Daichi Fujimoto, Takeshi Morimoto, Toru Kumagai, Akihiro Tamiya, Yoshihiko Taniguchi, Toshihide Yokoyama, Tadashi Ishida, Katsuya Hirano, Hirotaka Matsumoto, Ryota Kominami, Keisuke Tomii, Hidekazu Suzuki, Tomonori Hirashima, Junji Uchida, Mitsunori Morita, Masaki Kanazu, Nobuhiko Sawa, Takeshi Makio, Satoshi Hara, Motohiro Tamiya